The omega-3 fatty acids EPA and DHA decrease plasma F(2)-isoprostanes: Results from two placebo-controlled interventions. (Q43029510)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20540666%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

title

The omega-3 fatty acids EPA and DHA decrease plasma F(2)-isoprostanes: Results from two placebo-controlled interventions (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20540666%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20540666%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

5

Lawrence J Beilin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20540666%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

author name string

Emilie Mas

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20540666%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Valerie Burke

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20540666%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Ian B Puddey

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20540666%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Thierry Durand

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20540666%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Trevor A Mori

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20540666%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

publication date

1 September 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20540666%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

Free Radical Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20540666%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

volume

44

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20540666%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

page(s)

983-990

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20540666%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20540666%20AND%20SRC:MED&resulttype=core&format=json

F2-isoprostanes in human health and diseases: from molecular mechanisms to clinical implications

5 February 2020

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.492830

Formation of novel non-cyclooxygenase-derived prostanoids (F2-isoprostanes) in carbon tetrachloride hepatotoxicity. An animal model of lipid peroxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.492830

Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.492830

Factors regulating isoprostane formation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.492830

Protection against oxidative stress-induced hepatic injury by intracellular type II platelet-activating factor acetylhydrolase by metabolism of oxidized phospholipids in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.492830

Release of free F2-isoprostanes from esterified phospholipids is catalyzed by intracellular and plasma platelet-activating factor acetylhydrolases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.492830

Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.492830

Quantification of F-ring isoprostane-like compounds (F4-neuroprostanes) derived from docosahexaenoic acid in vivo in humans by a stable isotope dilution mass spectrometric assay

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.492830

The biochemistry of the isoprostane, neuroprostane, and isofuran Pathways of lipid peroxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.492830

Regiochemistry of neuroprostanes generated from the peroxidation of docosahexaenoic acid in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.492830

Novel eicosapentaenoic acid-derived F3-isoprostanes as biomarkers of lipid peroxidation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.492830

Dietary supplementation of omega-3 fatty acid-containing fish oil suppresses F2-isoprostanes but enhances inflammatory cytokine response in a mouse model of ovalbumin-induced allergic lung inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.492830

Effect of fish and fish oil-derived omega-3 fatty acids on lipid oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.492830

Long-term fish consumption and n-3 fatty acid intake in relation to (sudden) coronary heart disease death: the Zutphen study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.492830

Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.492830

Suppressive effect of EPA on the incidence of coronary events in hypercholesterolemia with impaired glucose metabolism: Sub-analysis of the Japan EPA Lipid Intervention Study (JELIS).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.492830

Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.492830

Omega-3 polyunsaturated fatty acids and cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.492830

Effect of eicosapentaenoic acid and docosahexaenoic acid on oxidative stress and inflammatory markers in treated-hypertensive type 2 diabetic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.492830

Fish oil supplementation in pregnancy lowers F2-isoprostanes in neonates at high risk of atopy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.492830

Polyunsaturated fatty acids as antioxidants.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.492830

Polyunsaturated fatty acid enrichment enhances endothelial cell-induced low-density-lipoprotein peroxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.492830

Rate constants for peroxidation of polyunsaturated fatty acids and sterols in solution and in liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.492830

Omega-3 fatty acids and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.492830

Dietary modification of inflammation with lipids.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.492830

Polyunsaturated fatty acids and inflammatory processes: New twists in an old tale

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.492830

N-3 polyunsaturated fatty acids and inflammation: from molecular biology to the clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.492830

n-3 polyunsaturated fatty acids and cytokine production in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.492830

Docosahexaenoic acid ingestion inhibits natural killer cell activity and production of inflammatory mediators in young healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.492830

Anti-inflammatory and proresolving lipid mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.492830

Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.492830

Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.492830

Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.492830

Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.492830

Oxidized derivatives of ω-3 fatty acids: identification of IPF3α-VI in human urine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.492830

Formation of F-ring Isoprostane-like Compounds (F3-Isoprostanes)in Vivofrom Eicosapentaenoic Acid

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.492830